Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + XP in Advanced Gastric Cancer
NCT00565370Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in gastric cancer (GC), sponsored by Asan Medical Center. Started Nov 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00565370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565370.